{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:13:42Z","timestamp":1783743222476,"version":"3.55.0"},"reference-count":28,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The detection of Kappa (\u03ba) and Lambda (\u03bb) light chains is crucial for the diagnosis and management of diseases such as multiple myeloma. Abnormal secretion of \u03ba and \u03bb light chains can be assessed quantitatively or qualitatively using various methods. This study aimed to compare the outcomes of \u03ba and \u03bb light chains and their ratio (\u03ba\/\u03bb) in different patients with and without monoclonal gammopathies, utilizing flow cytometry, serum free light chain assays, and gel immunofixation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective study included data from 92 patients, both with and without monoclonal gammopathy. Patients were categorized into two groups based on serum protein electrophoresis and immunofixation: those with positive monoclonal bands (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200977) and those without (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915). Simultaneous assessments of bone marrow plasma cells were conducted using flow cytometry, along with serum free \u03ba and \u03bb light chain assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After natural logarithm transformation, the serum \u03ba\/\u03bb ratio was compared to the flow cytometry results for plasma cells. The \u03ba\/\u03bb ratios showed a stronger association between serum free light chains and abnormal plasma cells (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.84,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) compared to normal plasma cells (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.32,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Additionally, chi\u2010squared analysis indicated a significant association for detecting free light chains for flow cytometry in comparison to serum immunofixation technique (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) with sensitivity and specificity of 94.2% and 47.6% respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Free light chain immunophenotyping using flow cytometry can serve as a complementary technique for identifying the type and quantity of positive free light chains in conjunction with immunofixation and serum free light chain assays.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ijlh.70180","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:56:20Z","timestamp":1783742180000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Assessment of Flow Cytometry Light Chains: Qualitative and Quantitative Evaluation Using Serum Protein Immunofixation and Free Light Chain Analysis"],"prefix":"10.1111","author":[{"given":"Anwar","family":"Borai","sequence":"first","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1749-3848","authenticated-orcid":false,"given":"Meaad","family":"Almowaled","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam","family":"Tayeb","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Albarakati","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazeed","family":"Alshehri","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazid","family":"Alqarni","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Doman","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Awadh","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Alsheikh","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Alsinani","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultanah","family":"AlBoraie","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baraa","family":"Alhajhussein","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nohad","family":"Elhassan","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alsaeed","sequence":"additional","affiliation":[{"name":"King Saud Bin Abdulaziz University for Health Sciences  Jeddah Saudi Arabia"},{"name":"King Abdullah International Medical Research Centre  Jeddah Saudi Arabia"},{"name":"King Abdulaziz Medical City, Ministry of National Guard Health Affairs  Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"4","key":"e_1_2_13_2_1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0950-3536(05)80255-0","article-title":"Plasma Cell Dyscrasias: Classification, Clinical and Laboratory Characteristics, and Differential Diagnosis","volume":"8","author":"Boccadoro M.","year":"1995","journal-title":"Bailli\u00e8re's Clinical Haematology"},{"issue":"1","key":"e_1_2_13_3_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for Diagnosis, Staging, Risk Stratification and Response Assessment of Multiple Myeloma","volume":"23","author":"Kyle R. A.","year":"2009","journal-title":"Leukemia"},{"issue":"10","key":"e_1_2_13_4_1","first-page":"649","article-title":"Multiple Myeloma: Current Status and Future Perspectives","volume":"32","author":"Qiu L. G.","year":"2011","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"e_1_2_13_5_1","unstructured":"Institute NC \u201cMyeloma\u2014Cancer Stat Facts. SEER: NIH \u201d2024 https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html."},{"key":"e_1_2_13_6_1","unstructured":"Council SH \u201cCancer Incidence Report Saudi Arabia 2020: Saudi Health Council \u201d2020 https:\/\/shc.gov.sa\/sites\/English\/Arabic\/NCC\/Activities\/AnnualReports\/Cancer%20Incidence%20Report%202020."},{"issue":"9","key":"e_1_2_13_7_1","first-page":"1458","article-title":"The Role of Serum Protein Electrophoresis in the Detection of Multiple Myeloma: An Experience of a Corporate Hospital","volume":"6","author":"Tripathy S.","year":"2012","journal-title":"Journal of Clinical and Diagnostic Research: JCDR"},{"issue":"4","key":"e_1_2_13_8_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000212077","article-title":"Serum Protein Electrophoresis: An Underused But Very Useful Test","volume":"79","author":"Vavricka S. R.","year":"2009","journal-title":"Digestion"},{"issue":"4","key":"e_1_2_13_9_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/clinchem\/22.4.497","article-title":"Immunofixation. I. General Principles and Application to Agarose Gel Electrophoresis","volume":"22","author":"Ritchie R.","year":"1976","journal-title":"Clinical Chemistry"},{"issue":"8","key":"e_1_2_13_10_1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening Panels for Detection of Monoclonal Gammopathies","volume":"55","author":"Katzmann J. A.","year":"2009","journal-title":"Clinical Chemistry"},{"issue":"1","key":"e_1_2_13_11_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 Patients With Newly Diagnosed Multiple Myeloma","volume":"78","author":"Kyle R. A.","year":"2003","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.38053\/acmj.1429510","article-title":"The Correlation Between Serum Free Light Chain Levels and Plasma Cell Ratio in Bone Marrow Biopsy in Multiple Myeloma","volume":"6","author":"Ye\u015filaltay A.","year":"2024","journal-title":"Anatolian Current Medical Journal"},{"issue":"1","key":"e_1_2_13_13_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bjhh.2015.11.003","article-title":"Serum Free Light Chain Assays Not Total Light Chain Assays Are the Standard of Care to Assess Monoclonal Gammopathies","volume":"38","author":"Tietsche de Moraes Hungria V.","year":"2016","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"issue":"4","key":"e_1_2_13_14_1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","article-title":"Flow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple Myeloma","volume":"121","author":"Lin P.","year":"2004","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_13_15_1","unstructured":"Cytognos Flow Cytometry Solutions \u201cEuroFlow HaemOnc Panels Cytognos Brochure.pdf \u201dhttps:\/\/www.abacusdx.com\/media\/EuroFlow%20HaemOnc%20Panels%20Cytognos%20Brochure.pdf."},{"issue":"4","key":"e_1_2_13_16_1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2141.2002.03513.x","article-title":"Clinicopathological and Prognostic Characteristics of CD56\u2010Negative Multiple Myeloma","volume":"117","author":"Sahara N.","year":"2002","journal-title":"British Journal of Haematology"},{"issue":"3","key":"e_1_2_13_17_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.leukres.2013.12.007","article-title":"Flow Cytometric Differentiation of Abnormal and Normal Plasma Cells in the Bone Marrow in Patients with Multiple Myeloma and Its Precursor Diseases","volume":"38","author":"Tembhare P. R.","year":"2014","journal-title":"Leukemia Research"},{"issue":"10","key":"e_1_2_13_18_1","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2017.29","article-title":"Next Generation Flow for Highly Sensitive and Standardized Detection of Minimal Residual Disease in Multiple Myeloma","volume":"31","author":"Flores\u2010Montero J.","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"e_1_2_13_19_1","first-page":"e352","article-title":"Assessment of Response to Therapy in Multiple Myeloma by Multiparameter Flow Cytometry. Usefulness of an Eight\u2010Color Single Tube With Monoclonal Antibodies in Dried Formulation","volume":"170","author":"Carulli G.","year":"2019","journal-title":"Clinica Terapeutica"},{"issue":"9","key":"e_1_2_13_20_1","first-page":"3095","article-title":"Flow Cytometric Disease Monitoring in Multiple Myeloma: The Relationship Between Normal and Neoplastic Plasma Cells Predicts Outcome After Transplantation","volume":"100","author":"Rawstron A. C.","year":"2002","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"11","key":"e_1_2_13_21_1","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/bloodadvances.2021006762","article-title":"Mass Spectrometry vs Immunofixation for Treatment Monitoring in Multiple Myeloma","volume":"6","author":"Puig N.","year":"2022","journal-title":"Blood Advances"},{"issue":"2","key":"e_1_2_13_22_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41408-021-00428-0","article-title":"Minimal Residual Disease Negativity by Next\u2010Generation Flow Cytometry is Associated With Improved Organ Response in AL Amyloidosis","volume":"11","author":"Palladini G. A.\u2010O.","year":"2021","journal-title":"Blood Cancer Journal"},{"issue":"4","key":"e_1_2_13_23_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cyto.b.20512","article-title":"Utility of Flow Cytometry Immunophenotyping in Multiple Myeloma and Other Clonal Plasma Cell\u2010Related Disorders","volume":"78","author":"Paiva B.","year":"2010","journal-title":"Cytometry. Part B, Clinical Cytometry"},{"issue":"8","key":"e_1_2_13_24_1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jclinpath-2012-200669","article-title":"Association of Plasma Cell Subsets in the Bone Marrow and Free Light Chain Concentrations in the Serum of Monoclonal Gammopathy Patients","volume":"65","author":"Ayliffe M. J.","year":"2012","journal-title":"Journal of Clinical Pathology"},{"key":"e_1_2_13_25_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1746-1596-7-131","article-title":"An Approach for Diagnosing Plasma Cell Myeloma by Three\u2010Color Flow Cytometry Based on Kappa\/Lambda Ratios of CD38\u2010Gated CD138(+) Cells","volume":"7","author":"Nakayama S.","year":"2012","journal-title":"Diagnostic Pathology"},{"issue":"2","key":"e_1_2_13_26_1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/039463201302600221","article-title":"An Approach for Plasma Cell Myeloma Diagnosis by Two\u2010Color Flow Cytometry Based on Kappa\/Lambda Ratios of CD38\u2010Gated Plasma Cells","volume":"26","author":"Nakayama S.","year":"2013","journal-title":"International Journal of Immunopathology and Pharmacology"},{"issue":"4","key":"e_1_2_13_27_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cyto.b.22062","article-title":"Flow Cytometric Immunophenotyping of Plasma Cells Across the Spectrum of Plasma Cell Proliferative Disorders: A Fresh Insight With Pattern\u2010Based Recognition","volume":"102","author":"Das N.","year":"2022","journal-title":"Cytometry Part B, Clinical Cytometry"},{"issue":"2","key":"e_1_2_13_28_1","first-page":"132","article-title":"Kappa\/Lambda Ratio on Peripheral Blood Lymphocytes and Bone Marrow Plasma Cell Labeling Index in Monoclonal Gammopathies","volume":"75","author":"Buchi G.","year":"1990","journal-title":"Haematologica"},{"issue":"1","key":"e_1_2_13_29_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41408-024-01201-9","article-title":"The Significance of Free Light\u2010Chain Ratio in Light\u2010Chain Monoclonal Gammopathy of Undetermined Significance: A Flow Cytometry Sub\u2010Study of the iStopMM Screening Study","volume":"14","author":"Oskarsson J.","year":"2024","journal-title":"Blood Cancer Journal"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.70180","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:56:24Z","timestamp":1783742184000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.70180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":28,"alternative-id":["10.1111\/ijlh.70180"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.70180","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"2025-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ijlh.70180"}}